Age at Diagnosis is an Independent Predictor of Small Renal Cell Carcinoma Recurrence-Free Survival
To access this article, please choose from the options below
Study received approval from the institutional review board at Asan Medical Center, Seoul, Republic of Korea.
Supported by Grant A062254 of the Korea Health 21 R
&
D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea.
For other articles on a related topic see pages 721, 728 and 735.
PII: S0022-5347(09)00898-2
doi:10.1016/j.juro.2009.04.013
© 2009 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- The bcl2 −938CC Genotype Has Poor Prognosis and Lower Survival in Renal Cancer , 18 June 2009
- CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis , 18 June 2009
- Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy , 18 June 2009

